Slow Capital Inc. Buys 229 Shares of Mettler-Toledo International, Inc. $MTD

Slow Capital Inc. boosted its stake in Mettler-Toledo International, Inc. (NYSE:MTD) by 5.4% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,469 shares of the medical instruments supplier’s stock after acquiring an additional 229 shares during the period. Slow Capital Inc.’s holdings in Mettler-Toledo International were worth $5,249,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Greenleaf Trust lifted its position in shares of Mettler-Toledo International by 1.2% during the 1st quarter. Greenleaf Trust now owns 872 shares of the medical instruments supplier’s stock valued at $1,030,000 after buying an additional 10 shares during the last quarter. Brooklyn Investment Group lifted its holdings in Mettler-Toledo International by 12.8% during the 1st quarter. Brooklyn Investment Group now owns 88 shares of the medical instruments supplier’s stock worth $104,000 after purchasing an additional 10 shares in the last quarter. Sequoia Financial Advisors LLC lifted its holdings in shares of Mettler-Toledo International by 1.8% in the first quarter. Sequoia Financial Advisors LLC now owns 627 shares of the medical instruments supplier’s stock worth $740,000 after buying an additional 11 shares in the last quarter. Albion Financial Group UT grew its position in shares of Mettler-Toledo International by 1.5% during the 1st quarter. Albion Financial Group UT now owns 754 shares of the medical instruments supplier’s stock valued at $890,000 after purchasing an additional 11 shares in the last quarter. Finally, TD Private Client Wealth LLC grew its holdings in shares of Mettler-Toledo International by 5.4% during the first quarter. TD Private Client Wealth LLC now owns 214 shares of the medical instruments supplier’s stock worth $253,000 after purchasing an additional 11 shares in the last quarter. Institutional investors own 95.07% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on MTD shares. Citigroup upped their price objective on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a “buy” rating in a report on Thursday, August 21st. Evercore ISI dropped their price target on shares of Mettler-Toledo International from $1,280.00 to $1,275.00 and set an “outperform” rating for the company in a research report on Monday, August 4th. Barclays raised their target price on Mettler-Toledo International from $1,325.00 to $1,350.00 and gave the stock an “overweight” rating in a research note on Thursday, October 2nd. Robert W. Baird raised their target price on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a “neutral” rating in a research report on Monday, August 4th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Mettler-Toledo International in a research report on Saturday, September 27th. Five equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat, Mettler-Toledo International presently has a consensus rating of “Hold” and a consensus price target of $1,328.33.

Mettler-Toledo International Price Performance

Shares of Mettler-Toledo International stock opened at $1,345.35 on Tuesday. The stock has a market cap of $27.71 billion, a price-to-earnings ratio of 34.07, a PEG ratio of 3.94 and a beta of 1.37. Mettler-Toledo International, Inc. has a 1 year low of $946.69 and a 1 year high of $1,486.76. The firm’s 50-day moving average is $1,273.95 and its 200 day moving average is $1,187.04.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 EPS for the quarter, beating analysts’ consensus estimates of $9.58 by $0.51. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The firm had revenue of $983.22 million for the quarter, compared to analysts’ expectations of $957.41 million. During the same quarter in the prior year, the company posted $9.65 earnings per share. The business’s revenue for the quarter was up 3.9% on a year-over-year basis. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. On average, equities analysts expect that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

Insider Activity

In other news, Director Thomas P. Salice sold 1,062 shares of the firm’s stock in a transaction dated Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the sale, the director owned 283 shares of the company’s stock, valued at $368,154.70. This trade represents a 78.96% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Shawn Vadala sold 300 shares of the business’s stock in a transaction that occurred on Friday, August 8th. The shares were sold at an average price of $1,254.09, for a total transaction of $376,227.00. Following the transaction, the chief financial officer directly owned 5,095 shares of the company’s stock, valued at $6,389,588.55. The trade was a 5.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 1,827 shares of company stock valued at $2,371,208 over the last ninety days. 0.77% of the stock is currently owned by corporate insiders.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.